Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10051713 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL116376 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL987953 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL438257 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL7799602 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL17586846 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL272664 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL9183077 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL12570287 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL13566433 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| US-12095081-B2 | Electrolytic solution and electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20240014378-A1 | POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
| CN-116918095-A | Positive electrode and electrochemical device | 株式会社村田制作所 | 2023-10-20 | — | — | CN | disclosed |
| US-20230223525-A1 | ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2023-07-13 | — | — | US | disclosed |
| CN-116250124-A | Electrochemical device | 株式会社村田制作所 | 2023-06-09 | — | — | CN | disclosed |
| WO-2022209595-A1 | POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE | 株式会社村田製作所 | 2022-10-06 | — | — | WO | disclosed |
| WO-2022054813-A1 | ELECTROCHEMICAL DEVICE | 株式会社村田製作所 | 2022-03-17 | — | — | WO | disclosed |
| CN-112970131-A | Electrolyte solution and electrochemical device | 株式会社村田制作所 | 2021-06-15 | — | — | CN | disclosed |
| EP-3832772-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE | Murata Manufacturing Co., Ltd. (JP) | 2021-06-09 | — | — | EP | disclosed |
| US-7960040-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20110020700-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY CELL, AND SECONDARY CELL | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2270917-A1 | SECONDARY CELL NONAQUEOUS ELECTROLYTE AND SECONDARY CELL | Asahi Glass Company, Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20070202356-A1 | Organic electroluminescence device | FUJIFILM CORPORATION | 2007-08-30 | — | — | US | disclosed |
| US-20070202356-A1 | Organic electroluminescence device | FUJIFILM CORPORATION | 2007-08-30 | — | — | US | disclosed |
| EP-1088835-B1 | Aqueous emulsion and method for producing it | KURARAY CO (JP) | 2004-12-22 | — | — | EP | disclosed |
| CN-1116351-C | Aqueous solution and its producing method | KURARAY CO (JP) | 2003-07-30 | — | — | CN | disclosed |
| US-6451898-B1 | Aqueous emulsion and method for producing it | KURARAY CO., LTD. (JP) | 2002-09-17 | — | — | US | disclosed |
| CN-1292399-A | Aqueous solution and its producing method | KURARAY CO (JP) | 2001-04-25 | — | — | CN | disclosed |
| EP-1088835-A1 | Aqueous emulsion and method for producing it | Kuraray Co., Ltd. (JP) | 2001-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | HSD17B10 2045/4885MEN1 1871/4885KMT2A 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.